Article details
Dallah Healthcare Co. has completed its acquisition of the remaining 2.59% stake in Al-Ahsa Medical Services Co., increasing its ownership to 100%. The SAR 10.88 million deal, funded through internal resources, was finalized following court approval and adherence to Saudi Companies Law. Previously, Dallah held 97.41% of Al-Ahsa, with the remaining stake acquired in April 2025 after a transaction with AYYAN Investment Co. in August 2024. Revenue projections for Al-Ahsa show SAR 264.64 million in 2023, SAR 276.77 million in 2024, and SAR 266.45 million in 2025.
This acquisition consolidates Dallah's control over a key healthcare asset, potentially enhancing operational efficiency and revenue stability. For traders, the move signals strategic growth in the Saudi healthcare sector, which could attract investor interest. Full ownership may reduce corporate governance risks and streamline decision-making. Market participants should monitor Dallah's stock performance post-acquisition and future earnings reports for Al-Ahsa.
For MENA investors, the transaction reflects confidence in Saudi healthcare infrastructure and privatization efforts. The absence of related parties in the deal suggests transparency, which could bolster investor trust. Key watchpoints include Al-Ahsa's revenue trends against projections and Dallah's integration strategy. The healthcare sector in Saudi Arabia remains a priority under Vision 2030, making such consolidations strategically significant.
